- Home
- OSUR vs CRMD Comparison
OSUR vs CRMD Comparison
Compare OSUR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | CRMD |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.5M | 590.7M |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | OSUR | CRMD |
|---|---|---|
| Price | $3.92 | $7.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 577.7K | ★ 750.8K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.72 |
| Revenue | $167,064,000.00 | ★ $311,709,000.00 |
| Revenue This Year | $6.16 | $8.13 |
| Revenue Next Year | $9.09 | N/A |
| P/E Ratio | ★ N/A | $10.17 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $2.08 | $6.13 |
| 52 Week High | $4.58 | $13.02 |
Technical Indicators
Market Signals| Indicator | OSUR | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 38.67 |
| Support Level | $3.89 | $7.09 |
| Resistance Level | $3.93 | $7.44 |
| Average True Range (ATR) | 0.19 | 0.22 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 54.32 | 27.43 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.